Corbus Pharmaceuticals Holdings, Inc. Investment Income, Interest
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Investment Income, Interest of $12.65 thousand for the 3-month period ending 2020-06-30, per its 10-Q/A filed 2020-08-31.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2020-08-31
- Corbus Pharmaceuticals Holdings, Inc. investment income, interest for the quarter ending 2020-06-30 was $12.65K, a 97.18% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. investment income, interest for the quarter ending 2020-03-31 was $101.99K, a 69.52% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. investment income, interest for the quarter ending 2019-06-30 was $448.72K.
- Corbus Pharmaceuticals Holdings, Inc. investment income, interest for the quarter ending 2019-03-31 was $334.60K.
- Corbus Pharmaceuticals Holdings, Inc. investment income, interest for fiscal 2019 was $1.23M, a 24.92% increase from fiscal 2018.
- Corbus Pharmaceuticals Holdings, Inc. investment income, interest for fiscal 2018 was $982.78K.
- Corbus Pharmaceuticals Holdings, Inc. investment income, interest for fiscal 2015 was $3.42K, a 61.56% increase from fiscal 2014.
- Corbus Pharmaceuticals Holdings, Inc. investment income, interest for fiscal 2014 was $2.12K, a 180.50% increase from fiscal 2013.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2020-06-30 | $12.65K 10-Q/A · filed 2020-08-31 | $114.64K 10-Q/A · filed 2020-08-31 | ||
| 2020-03-31 | $101.99K 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $1.23M 10-K · filed 2020-03-16 | |||
| 2019-06-30 | $448.72K 10-Q/A · filed 2020-08-31 | $783.31K 10-Q/A · filed 2020-08-31 | ||
| 2019-03-31 | $334.60K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $982.78K 10-K · filed 2020-03-16 | |||
| 2016-03-31 | $1.07K 10-Q · filed 2016-05-13 | $2.34K derived: sum of 2 quarters · filed 2016-05-13 | $3.38K derived: sum of 3 quarters · filed 2016-05-13 | $3.93K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-12-31 | $1.27K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $2.31K derived: sum of 2 quarters · filed 2016-03-28 | $2.86K derived: sum of 3 quarters · filed 2016-03-28 | $3.42K 10-K · filed 2016-03-28 |
| 2015-09-30 | $1.04K 10-Q · filed 2015-11-10 | $1.58K derived: sum of 2 quarters · filed 2015-11-10 | $2.15K 10-Q · filed 2015-11-10 | $2.83K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-06-30 | $548.00 10-Q · filed 2015-08-13 | $1.11K 10-Q · filed 2015-08-13 | $1.80K derived: sum of 3 quarters · filed 2016-05-13 | $2.60K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-03-31 | $560.00 10-Q · filed 2016-05-13 | $1.25K derived: sum of 2 quarters · filed 2016-05-13 | $2.05K derived: sum of 3 quarters · filed 2016-05-13 | $2.63K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $690.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $1.49K derived: sum of 2 quarters · filed 2016-03-28 | $2.07K derived: sum of 3 quarters · filed 2016-03-28 | $2.12K 10-K · filed 2016-03-28 |
| 2014-09-30 | $802.00 10-Q · filed 2015-11-10 | $1.38K derived: sum of 2 quarters · filed 2015-11-10 | $1.43K 10-Q · filed 2015-11-10 | $1.48K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $578.00 10-Q · filed 2015-08-13 | $623.00 10-Q · filed 2015-08-13 | $682.00 derived: sum of 3 quarters · filed 2015-08-13 | $810.00 derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $45.00 10-Q · filed 2015-05-13 | $104.00 derived: sum of 2 quarters · filed 2015-05-13 | $232.00 derived: sum of 3 quarters · filed 2015-05-13 | |
| 2013-12-31 | $59.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | $187.00 derived: sum of 2 quarters · filed 2015-02-10 | $754.00 10-K · filed 2015-02-10 | |
| 2013-09-30 | $128.00 10-Q · filed 2014-11-13 | $695.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |